Investors of Revlon Inc (NYSE:REV) must be quite happy as the company has gained as much as 34.9% since the beginning of the year. The company is in the portfolios of several famous investors, including Joel Greenblatt and Jim Simons. Interestingly, being the shareholders of Revlon means investors can invest alongside billionaire Ronald Perelman. He owns 76.3% of the total A shares and 100% of the company’s B shares. Should investors buy Revlon Inc (NYSE:REV) shares at its current trading price? Let’s find out.
Positive cash flow but weak balance sheet
Revlon is the manufacturer of various cosmetics, beauty tools, deodorants and fragrance products under several brand names, including Revlon Inc (NYSE:REV), Almay, SinfulColors and Pure Ice. Revlon concentrates its business in the U.S., generating nearly $800 million in revenue in 2012. The Asia Pacific region ranks second at nearly $240 million.
For the past four years, Revlon managed to produce consistently increasing revenue, from $1.3 billion in 2009 to nearly $1.43 billion in 2012. However, the net income has fluctuated wildly in the same period, in the range of $49 million to $327 million. In 2012, its net income came in at $51 million. The high net income in 2010 was mainly due to more than $247 million benefit from provision for income taxes. In 2012, it generated $104 million in operating income and $83 million in free cash flow.
What makes me worry is its weak balance sheet position. As of March 2013, it had negative equity of $(655) million, $121 million in cash and as much as $1.23 billion in long-term debt. Revlon Inc (NYSE:REV) is trading at $19.50 per share, with the total market cap of $1 billion. The market does not value Revlon expensively, at more than 9 times its trailing EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization).
The cheapest valued among its peers
However, compared to its peers Coty Inc (NYSE:COTY) and Avon Products, Inc. (NYSE:AVP), Revlon Inc (NYSE:REV) seems to be relatively cheaply valued. Coty is trading at $17 per share, with the total market cap of $6.5 billion. The market values Coty Inc (NYSE:COTY) at much higher valuation, at 12.5 times its trailing EBITDA. Like Revlon, Coty Inc (NYSE:COTY) also had highly leveraged balance sheet. It had $869 million in equity, nearly $610 million and cash and more than $2.46 billion in debt. Avon also employed a lot of debt in its operations. The company booked nearly $1.18 billion in equity, nearly $1.49 billion in cash, and more than $3.63 billion in debt. Avon Products, Inc. (NYSE:AVP)also has higher valuation than Revlon. At $20.80 per share, Avon is worth around $9 billion. Avon Products, Inc. (NYSE:AVP) is valued at around 12.1 times its trailing EBITDA.
